CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-10-21: Form 8-K; Period of report 2015-10-21; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-10-13: Form 8-K; Period of report 2015-10-13; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2015-09-29: Form 8-K; Period of report 2015-09-29; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2015-07-22: Form 8-K; Period of report 2015-07-22; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-10-21 | 8-K | 2015-10-21 | 2.02 Results of Operations and Financial Condition | 2.02 On October 21, 2015, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2015. | clb-2015q3_earningsrelease.htm |
| 2015-10-13 | 8-K | 2015-10-13 | 7.01 Regulation FD Disclosure | 7.01 On October 13, 2015, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on October 23, 2015 and payable November 24, 2015. | clb-8k_dividend4q2015.htm |
| 2015-09-29 | 8-K | 2015-09-29 | 7.01 Regulation FD Disclosure | 7.01 On September 29, 2015, Core Laboratories N.V. issued a press release simultaneously with the publication of a prepared set of questions and answers by our Chairman and CEO at the Johnson Rice Energy conference in New Orleans. | a8k_clb-qainformation.htm |
| 2015-07-22 | 8-K | 2015-07-22 | 2.02 Results of Operations and Financial Condition | 2.02 On July 22, 2015, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2015. | clb-2015q2_earningsrelease.htm |
| 2015-07-07 | 8-K | 2015-07-07 | 7.01 Regulation FD Disclosure | 7.01 On July 7, 2015, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on July 17, 2015 and payable August 17, 2015. | clb-8k_dividend3q2015.htm |
| 2015-05-22 | 8-K | 2015-05-21 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 21, 2015 in Amsterdam, The Netherlands. | a2015annualshareholdermeet.htm |
| 2015-05-04 | 8-K | 2015-05-04 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 As disclosed in its definitive proxy statement filed on March 20, 2015, Core Laboratories N.V. (the “Company”) intends to appoint the U.S. and Dutch member firms of KPMG (collectively, “KPMG”) to serve as the Company’s Independent Registered Public Accounting Firm for the year ending December 31, 2016, subject to the negotiation and execution of a satisfactory engagement letter and the approval of the Company’s shareholders at its May 21, 2015 annual meeting (the “annual meeting”). | a8k_clb-changeinauditfirm.htm |
| 2015-04-22 | 8-K | 2015-04-22 | 2.02 Results of Operations and Financial Condition | 2.02 On April 22, 2015, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2015. | clb-2015q1_earningsrelease.htm |
| 2015-04-13 | 8-K | 2015-04-13 | 7.01 Regulation FD Disclosure | 7.01 On April 13, 2015, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on April 24, 2015 and payable May 22, 2015. | clb-8k_dividend2q2015.htm |
| 2015-03-16 | 8-K | 2015-03-16 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On March 13, 2015, Core Laboratories N.V. and Core Laboratories (U.S.) Interests Holdings, Inc. entered into Amendment No. 1 (the “Amendment”) to their Sixth Amended and Restated Credit Agreement, dated as of August 29, 2014 (together with the Amendment, the “Amended Credit Agreement”), with various financial institutions which are parties to the Amended Credit Agreement (collectively, the “Lenders”), with Bank of America, N.A. also serving as administrative agent for the Lenders, swingline lender and as a letter of credit issuing bank. | a8k_clb-debtannouncementx0.htm |
| 2015-01-28 | 8-K | 2015-01-28 | 2.02 Results of Operations and Financial Condition | 2.02 On January 28, 2015, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2014 and full year ended December 31, 2014. | clb-2014q4_earningsrelease.htm |
| 2015-01-12 | 8-K | 2015-01-12 | 7.01 Regulation FD Disclosure | 7.01 On January 12, 2015, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on January 23, 2015 and payable February 20, 2015. | clb-8k_dividend1q2015.htm |